Huachansu mediates cell death in non-Hodgkin's lymphoma by induction of caspase-3 and inhibition of MAP kinase

被引:33
作者
Efuet, Ekem T. [1 ]
Ding, Xiao-Ping [1 ]
Cartwright, Carrie [1 ]
Pan, Yong [1 ]
Cohen, Lorenzo [1 ]
Yang, Peiying [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Integrat Med Program, Dept Gen Oncol, Houston, TX 77030 USA
关键词
Huachansu; non-Hodgkin's lymphomas; apoptosis; caspase; MAP kinase; HUMAN HEPATOCELLULAR-CARCINOMA; ECTEINASCIDIN-743; ET-743; LUNG-CANCER; APOPTOSIS; BUFALIN; CINOBUFACINI; PATHWAY; BUFADIENOLIDES; PROLIFERATION; MECHANISMS;
D O I
10.3892/ijo.2015.3044
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Huachansu (HCS), a hot water extract of the skin glands of Bufo gargarizans (B. melanostictus), has been used extensively in the treatment of various solid tumors in Asia, particularly in China. However, its effect on the growth of malignancies of hematopoietic origin, particularly lymphomas, is limited. Here we investigated the antiproliferative effect and molecular mechanisms of HCS using non-Hodgkin's lymphoma (NHL) Raji, Ramos, and Namalwa cells and the mantle cell lymphoma cells SP53. HCS inhibited proliferation in these cell lines with an IC50 ranging from 3.1 to 25 mu l/ml. At a concentration of 25 mu l/ml, HCS triggered a sub-G1 arrest in Ramos cells and induced early to late apoptotic cell death. Cleaved caspase-3 was formed in a concentration-dependent manner in Ramos cells following treatment with HCS for 24 h. Intriguingly, when the Ramos cells were treated with the caspase inhibitor ZDEVD, the apoptotic activity of HCS was partially blocked. Furthermore, HCS also blocked the expression of survivin and pRB proteins in a concentration-dependent manner in Ramos cells. Mechanistically, HCS downregulated both the MAPK gene and proteins in Ramos cells. Collectively, our data suggest that HCS is effective in inducing cell death and apoptosis, in part, by activating caspase-3 activity and suppressing MAP kinase in NHL cells.
引用
收藏
页码:592 / 600
页数:9
相关论文
共 42 条
[1]
Ara-C affects formation of cancer cell DNA synthesome replication intermediates [J].
Abdel-Aziz, W ;
Jiang, HY ;
Hickey, RJ ;
Malkas, LH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (04) :312-319
[2]
Mechanisms of caspase activation [J].
Boatright, KM ;
Salvesen, GS .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (06) :725-731
[3]
Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[4]
Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line [J].
Chen, Rong ;
Chubb, Sherri ;
Cheng, Tiewei ;
Hawtin, Rachael E. ;
Gandhi, Varsha ;
Plunkett, William .
CANCER RESEARCH, 2010, 70 (16) :6587-6597
[5]
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action [J].
Erba, E ;
Bergamaschi, D ;
Bassano, L ;
Damia, G ;
Ronzoni, S ;
Faircloth, GT ;
D'Incalci, M .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) :97-105
[6]
Non-Hodgkin lymphoma [J].
Evans, LS ;
Hancock, BW .
LANCET, 2003, 362 (9378) :139-146
[7]
ET-743:: A novel agent with activity in soft tissue sarcomas [J].
Fayette, J ;
Coquard, IR ;
Alberti, L ;
Ranchère, D ;
Boyle, H ;
Blay, JY .
ONCOLOGIST, 2005, 10 (10) :827-832
[8]
Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens [J].
Filho, GAC ;
Schwartz, CA ;
Resck, IS ;
Murta, MM ;
Lemos, SS ;
Castro, MS ;
Kyaw, C ;
Pires, OR ;
Leite, JRS ;
Bloch, C ;
Schwartz, EF .
TOXICON, 2005, 45 (06) :777-782
[9]
New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma [J].
Frick, Mareike ;
Doerken, Bernd ;
Lenz, Georg .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (01) :3-12
[10]
Gomes A, 2010, INDIAN J EXP BIOL, V48, P93